|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Oral contraception and cardiovascular complications. [Anticoncepcionais |
| orais e complicacoes cardiovasculares.] |
| Arquivos Brasileiros de Cardiologia. 1983 Mar;40(3):215-21. |
| The effects of oral contraceptives (OCs) on the cardiovascular system depends on the age of the patient; length of |
| OC use; the quantity and type of estrogen and type of progestagen in the OC; individual predisposition; and the |
| association with other risk factors producing a synergistic effect. Mortality for cardiovascular complications is 3 to 4 |
| times greater in women who use OCs for a period of 1 to 59 months, and increases to 9.7 times after 60 months. |
| There are 3 principal complications associated with the use of OCs: arterial hypertension, acute myocardial |
| infacrtion, and thromboembolism. The use of a pill with a lower level of estrogen (50 mcg) decreases by 25%, but |
| does not eliminate, the risk of thromboembolism, but does not decrease the incidence of arterial hypertension and |
| acute myocardial infarction. Predisposing factors, clinical courses, mechanisms of action, and treatment of arterial |
| hypertension, thromboembolism, and acture myocardial infarction are discussed. Some well-established |
| recommendations for OC use are presented, including: 1) begin using an OC with a low level of estrogen; 2) women |
| over 35 should not use OCs, particularly if they are obses, hypertensive, or smokers; 3) use of tobacco should be |
| avoided; 4) the patient using OCs should not abuse alcoholic beverages; 5) suspending OC use for a short period |
| after 2 or 3 years of use represents little in terms of preventive medicine and only increases the chance of unwanted |
| pregnancy; 6) OCs should not be used in the presence or suspicion of pregnancy because of the potential danger of |
| congenital anomalies; 7) OCs should not be used by women who develop diabetes during pregnancy; 8) suspend |
| OCs 1 month before elective abdominal or pelvic surgery; 9) all patients using OCs should be examined every 6 |
| months. Oral contraception constitutes the most effective and safest method of birth control. Some of its |
| complications are serious and associated with significant morbidity. Nevertheless, if contraindications and |
| recommendations are observed, the incidence of complications can be reduced to a minimum. (PubHealth.info |
| Document ID: CONT5T 2060-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Oral contraception and cardiovascular complications. |
| [Anticoncepcionais orais e complicacoes cardiovasculares.]", is(are) Murad V. The source of this article is |
| "Arquivos Brasileiros de Cardiologia. 1983 Mar;40(3):215-21.". This article was published in 1983 in Portuguese |
| language(s). (PubHealth.info® Document ID: CONT5T 2060-06. All rights reserved with PubHealth.info) PIN: 22060 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |